Best Pharma Stocks in October 2026 Based on 5-Year CAGR: Neuland Laboratories, Wockhardt and More

The pharmaceutical sector has seen various companies demonstrate impressive growth over the past 5 years.  

This article highlights the top 10 pharma stocks based on their 5-year compound annual growth rate (CAGR), offering a glimpse into their financial performance and market standing. 

Top 10 Pharma Stocks Based on 5-Year CAGR in October 2026 

Note: The above data is as of September 29, 2026. 

Neuland Laboratories Limited 

Neuland Laboratories Limited leads with a 5-year CAGR of 68.6%. With a market cap of ₹27,423.89 crore and a close price of ₹21,375, the company has shown a 1-year return of 48.1%. The PE ratio stands at 75.34, while the return on equity is 21.42%. 

Wockhardt Limited 

Wockhardt Limited follows with a 5-year CAGR of 39.84%. Its market cap is ₹35,654.03 crore, and the close price is ₹2,194.2. The company has achieved a 1-year return of 40.26% and a PE ratio of 167.39. 

Marksans Pharma Limited 

Marksans Pharma Limited has a 5-year CAGR of 38.05%. The market cap is ₹15,532.19 crore, with a close price of ₹342.75. The 1-year return is 106.05%, and the PE ratio is 37.17. 

Glenmark Pharmaceuticals Limited 

Glenmark Pharmaceuticals Limited reports a 5-year CAGR of 36.83%. With a market cap of ₹68,905.15 crore and a close price of ₹2,441.5, the company has a 1-year return of 24.68% and a PE ratio of 50.6. 

Strides Pharma Science Limited 

Strides Pharma Science Limited has a 5-year CAGR of 35.1%. The market cap is ₹10,808.17 crore, and the close price is ₹1,172.6. The 1-year return is 43.82%, with a PE ratio of 19.43. 

Shilpa Medicare Limited 

Shilpa Medicare Limited shows a 5-year CAGR of 30.9%. Its market cap is ₹20,648.55 crore, and the close price is ₹1,055.75. The 1-year return is 175.19%, and the PE ratio is 84.86. 

Laurus Labs Limited 

Laurus Labs Limited has a 5-year CAGR of 26.97%. The market cap is ₹1,06,927.79 crore, with a close price of ₹1,979. The 1-year return is 135.33%, and the PE ratio is 120.31. 

Torrent Pharmaceuticals Limited 

Torrent Pharmaceuticals Limited reports a 5-year CAGR of 25.57%. With a market cap of ₹1,86,152.03 crore and a close price of ₹4,894, the company has a 1-year return of 36.45% and a PE ratio of 86.05. 

Caplin Point Laboratories Limited 

Caplin Point Laboratories Limited has a 5-year CAGR of 25.25%. The market cap is ₹20,857.61 crore, and the close price is ₹2,744. The 1-year return is 36.5%, with a PE ratio of 32.53. 

Granules India Limited 

Granules India Limited rounds off the list with a 5-year CAGR of 21.85%. The market cap is ₹23,643.19 crore, and the close price is ₹866.75. The 1-year return is 68.43%, and the PE ratio is 39.73. 

Read More: Lemon Tree Hotels Share Price in Focus; Opens New 71-Room Resort in Nashik! 

Conclusion 

The top 10 pharma stocks based on 5-year CAGR include Neuland Laboratories at 68.6%, Wockhardt at 39.84%, and Marksans Pharma at 38.05%. These companies have shown varied market caps, PE ratios, and 1-year returns. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.